National Institute of Dental and Craniofacial Research (NIDCR)
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, National Institute of Dental and Craniofacial Research (NIDCR) sits in the top decile of US sponsors by registered trial count (#259 of 15,742 sponsors by registered trial count).
National Institute of Dental and Craniofacial Research (NIDCR): 91 sponsored US clinical trials, 11 recruiting.
National Institute of Dental and Craniofacial Research (NIDCR) sponsors 91 registered US clinical trials on ClinicalTrials.gov, 11 of them currently recruiting, and 70 completed. 2 of these trials are in Phase 3-4 (later-stage) and 41 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Sjogren's Syndrome, with 6 trials.
Top-decile sponsor footprint
National Institute of Dental and Craniofacial Research (NIDCR) ranks in the top decile of sponsors by registered trial count (#259 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
70 of 78 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (89.7%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
91 total, page 2 of 2
Rofecoxib to Prevent Pain After Third Molar (Wisdom Tooth) Extraction
NCT00026819
Potential of Transplanted Stem Cells to Mature Into Salivary Gland and Cheek Cells
NCT00023491
A Study of the Effects of Pegvisomant on Growth Hormone Excess in McCune-Albright Syndrome
NCT00017927
Pain Evaluation and Treatment
NCT00362167
Topiramate in the Treatment of Sciatica
NCT00011804
Pain Treatment for Sciatica
NCT00009672
Capsaicin to Control Pain Following Third Molar Extraction
NCT00008476
Pathophysiology of Chronic Wounds
NCT00006437
Effects of Letrozole on Precocious Puberty Due to McCune Albright Syndrome
NCT00006174
Cyclooxygenase Levels Following Surgery to Remove Third Molars (Wisdom Teeth)
NCT00006175
Etanercept (Enbrel) to Treat Pain and Swelling After Third Molar Extraction
NCT00006070
Oral Manifestations of Aplastic Anemia
NCT00006300
Effects of Topical SLPI on Skin Wounds
NCT00005569
Influence of Genetics in Pain Sensitivity
NCT00001956
Eligibility Screening for National Institute of Dental and Craniofacial Research Studies
NCT00001983
Etanercept Therapy for Sjogren's Syndrome
NCT00001954
Celebrex for Pain Relief After Oral Surgery
NCT00006299
Study of Etanercept and Celecoxib to Treat Temporomandibular Disorders (Painful Joint Conditions)
NCT00001955
The Functioning of Immune and Hormonal Systems in Patients With Sjogren's Syndrome and in Healthy Volunteers
NCT00001953
Using a Narcotic to Enhance the Numbing Effect of the Local Anesthetic Lidocaine on Inflamed Molar Teeth
NCT00001952
Natural History of Salivary Gland Dysfunction and Sjogren's Syndrome
NCT00001852
Bone Marrow Injection to Replace Diseased Bone in Polyostotic Fibrous Dysplasia and McCune-Albright Syndrome
NCT00001851
Alendronate to Treat Polyostotic Fibrous Dysplasia and McCune-Albright Syndrome
NCT00001728
Study of the Composition of Dental Plaque
NCT00001726
Studies of Dextromethorphan and Topiramate to Treat Oral and Facial Pain
NCT00001725
Local Flurbiprofen to Treat Pain Following Wisdom Tooth Extraction
NCT00001724
Evaluation and Treatment of Oral Soft Tissue Diseases
NCT00001601
Diagnosis and Evaluation of Patients Needing Third Molar (Wisdom Tooth) Extraction and Patients With Chronic Facial Pain
NCT00001600
Pilot Study of Thalidomide to Treat Sjogren's Syndrome
NCT00001599
DHEA Treatment for Sjogren's Syndrome
NCT00001598
Pain Measurement in Healthy Volunteers
NCT00001597
Studies on Abnormal Bone From Patients With Polyostotic Fibrous Dysplasia and McCune Albright Syndrome
NCT00001973
Thalidomide to Treat Oral Lesions in HIV-Infected Patients
NCT00001524
Structure and Functional Status of Parotid Glands Exposed to Therapeutic Irradiation
NCT00001523
Bone Regeneration Using Bone Marrow Stromal Cells
NCT00001391
Salivary Evaluation in Healthy Volunteers
NCT00001390
Dextromethorphan Versus Placebo for Neuropathic Pain
NCT00001344
Positron Emission Tomography to Measure Pain and Pain Control
NCT00001307
Clinical Study of Oral Endosseous Titanium Implants in Edentulous Subjects
NCT00001211
Evaluation of Salivary Gland Dysfunction
NCT00001196
Evaluation of Patients With Unusual Diagnostic or Treatment Considerations
NCT00001182
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 9 |
| Phase 2 | 32 |
| Phase 3 | 2 |
Therapeutic Areas
What is open in the National Institute of Dental and Craniofacial Research (NIDCR) pipeline
11 recruiting of 91 indexed (12% open); 70 completed (77%).
Phase mix: 2 late (III/IV) vs 41 early (I/II) (early-phase heavy).
Top condition: Sjogren's Syndrome (6 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
National Institute of Dental and Craniofacial Research (NIDCR): open-pipeline peers nationwide
Peers matched on 91 registered trials and 12% open enrollment, not the therapeutic-area sidebar.
National Institute of Dental and Craniofacial Research (NIDCR) sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 91 trials (± recruiting share)
- University of Central Florida · 91 trials · 42% recruiting
- Children's National Research Institute · 92 trials · 38% recruiting
- Drexel University · 92 trials · 16% recruiting
- Loyola University · 92 trials · 13% recruiting
Sponsors near 12% open enrollment (± trial volume)
- East Carolina University · 12% recruiting · 58 trials
- Antonios Likourezos · 12% recruiting · 33 trials
- Oregon State University · 12% recruiting · 33 trials
- University of Massachusetts, Amherst · 12% recruiting · 33 trials
Related
What to do with this National Institute of Dental and Craniofacial Research (NIDCR) page
91 registered trials is a research-attention snapshot, not an endorsement of National Institute of Dental and Craniofacial Research (NIDCR) or any single study.
- 11 of National Institute of Dental and Craniofacial Research (NIDCR)'s trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Sjogren's Syndrome is the condition National Institute of Dental and Craniofacial Research (NIDCR) studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Sjogren's Syndrome trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
National Institute of Dental and Craniofacial Research (NIDCR) pipeline card: 91 registered trials from official public datasets.Report a data error.